EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A recombinant Marek’s disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens

Wenrui Fan iD, Xianying Zeng, Yuntong Chen iD, Qingqing Yu, Zibo Zhang, Guobin Tian, Changjun Liu, Hongmei Bao, Xiaole Qi, Longbo Wu, Yanping Zhang, Yongzhen Liu und 5 weitere

Journal of Virology · 23.10.2025 · 99 (10)

DOI: 10.1128/jvi.01149-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 23.10.2025. Verfasst von Wenrui Fan und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, The Chinese Academy of Agricultural Sciences, Harbin Veterinary Research Institute, H…. Hauptthemen laut MEDLINE: Infectious bursal disease virus, Influenza in Birds, Birnaviridae Infections, Poultry Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Agriculture Research System of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination is the most effective preventative measure against economically devastating poultry diseases, such as infectious bursal disease (IBD), H9 subtype avian influenza (AI), and Marek’s disease. In recent decades, various vaccination strategies have been investigated and developed. Among these, multivalent and combination vaccines, which confer protection against multiple diseases in a single dose, have emerged as a significant advancement in veterinary medicine. This study demonstrates that the attenuated Marek’s disease virus serotype 1 (MDV-1) vaccine strain, rMSΔMeq, known for its safety and robust carrier immunogenicity, can serve as a vector for the heterologous expression of multiple antigenic proteins. We constructed the recombinant virus rMDV-VP2-HA by inserting the H9 subtype avian influenza virus (AIV) hemagglutinin (HA) expression cassette into the UL41 region and the infectious bursal disease virus (IBDV) VP2 expression cassette into the US2 region. The growth characteristics of this recombinant virus were consistent with those of the parental virus, and it stably expressed the HA and VP2 genes. Vaccination with rMDV-VP2-HA induces high titers of IBDV-neutralizing antibodies and hemagglutinin inhibition (HI) antibodies and elicits strong cellular immune responses. Specifically, vaccination with rMDV-VP2-HA enhances interferon-gamma (IFN-γ) expression in response to stimulation with HA and VP2 proteins. Meanwhile, cytokines associated with both Th1 and Th2 responses were also upregulated. Remarkably, chickens vaccinated with rMDV-VP2-HA achieved complete protection against very virulent IBDV, H9 subtype AIV, and very virulent MDV. These findings underscore the exceptional practical potential of rMDV-VP2-HA as the first MDV-1 vector-based multivalent vaccine candidate for combating these poultry diseases. IMPORTANCE Commercial vaccines for infectious bursal disease (IBD) and H9 subtype avian influenza (AI) require multiple doses, increasing costs and causing stress in chicken flocks. Additionally, their efficacy is frequently compromised by maternal antibody interference. This underscores the urgent need for a multivalent, multi-component, and single-dose vaccines capable of streamlining immunization protocols, overcoming maternal antibody interference, and providing lifelong immunity. Our research demonstrates, for the first time, serotype 1 Marek’s disease virus (MDV-1) can stably express multiple exogenous genes. More significantly, the rMDV-VP2-HA elicits robust humoral and cellular immune responses, achieving complete protection against H9 subtype AIV, very virulent IBDV, and very virulent MDV with a single immunization. These findings contribute to enhancing the efficiency of disease prevention and confirm that the MDV-1 is an ideal vector for developing multivalent vaccines, achieving the goal of “multiple protections with a single shot.” This advancement represents a significant progression in the prevention and control of economically important poultry diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infectious bursal disease virusInfluenza in BirdsBirnaviridae InfectionsPoultry DiseasesMarek DiseaseMarek Disease VaccinesViral VaccinesAnimalsChickensAntibodies, ViralVaccines, SyntheticHemagglutinin Glycoproteins, Influenza VirusVaccinationInfluenza VaccinesVaccines, Attenuated

Stichwörter der Autor:innen

H9 subtype AIVHAIBDVMDV-1VP2vaccine

Substanzen

Antibodies, ViralVaccines, SyntheticHemagglutinin Glycoproteins, Influenza VirusMarek Disease VaccinesViral VaccinesInfluenza VaccinesVaccines, Attenuated

Autor:innen und Institutionen

  • State Key Laboratory for Animal Disease Control and Prevention, The Chinese Academy of Agricultural Sciences, Harbin Veterinary Research Institute, Harbin, PR China.

ORCID-Profile: Wenrui Fan, Yuntong Chen, Hualan Chen, Yulong Gao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Agriculture Research System of China
  • Innovation Program of the Chinese Academy of Agricultural Sciences

Zitieren

APA

Fan, W., Zeng, X., Chen, Y., Yu, Q., Zhang, Z., Tian, G., Liu, C., Bao, H., Qi, X., Wu, L., Zhang, Y., Liu, Y., Wang, S., Cui, H., Duan, Y., Chen, H., & Gao, Y. (2025). A recombinant Marek’s disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens. Journal of Virology, 99(10). https://doi.org/10.1128/jvi.01149-25

Vancouver

Fan W, Zeng X, Chen Y, Yu Q, Zhang Z, Tian G, et al. A recombinant Marek’s disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens. Journal of Virology. 2025;99(10). doi:10.1128/jvi.01149-25

BibTeX
@article{Fan2025,
  author = {Fan, Wenrui and Zeng, Xianying and Chen, Yuntong and Yu, Qingqing and Zhang, Zibo and Tian, Guobin and Liu, Changjun and Bao, Hongmei and Qi, Xiaole and Wu, Longbo and Zhang, Yanping and Liu, Yongzhen and Wang, Suyan and Cui, Hongyu and Duan, Yulu and Chen, Hualan and Gao, Yulong},
  title = {A recombinant Marek’s disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickens},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {10},
  doi = {10.1128/jvi.01149-25}
}
Kostenlos starten →